The Semaglutide weight loss management solution is ideal for adults with a BMI of 30 or greater or individuals with a BMI of 27 and at least one comorbidity related to body weight, such as high blood pressure, insulin resistance, high cholesterol, or heart disease
This information can support a more informed conversation about starting dose, titration pace, and medication choice
Retatrutide builds on that concept by incorporating an additional receptor target without abandoning the dual-incretin foundation
Vessel offers targeted peptide protocols including BPC-157, CJC/Ipamorelin, Tesamorelin, NAD+, and others
There are various stages in the progression of NALFD
Trulicity is prescribed for adults with type 2 diabetes to control blood sugar and reduce cardiovascular risks